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In rats fed a low-selenium diet, cytosolic GSH levels in the heart were significantly elevated when compared 
to rats fed a selenium-supplemented diet. Similar results were obtained in cardiac cytosol from rats treated 
with either parenteral or dietary Cd. Mitochondrial GSH was not affected by cadmium in selenium-deficient 
rats, However, significant elevations of mitochondrial GSH were seen in cadmium-treated rats fed either 
0.1 or 0.5 ppm selenium. The alterations in cytosolic GSH levels correlate with reductions in GSH-Px activi- 
ty reported earlier [( 1987) Toxicol. Appl. Pharmacol. 87, in press]. However, levels of mitochondrial GSH 
did not correlate with GSH-Px activity. 
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1. INTRODUCTION 
The reduced form of the tripeptide, glutathione 
(GSH), is depleted in the hypoxic heart [1,2]. 
Depressed cardiac contractility, following reperfu- 
sion injury in the isolated rabbit heart, has also 
been shown to involve significant reductions in 
myocardial GSH with no change in oxidized 
glutathione, glutathione reductase or glutathione 
peroxidase (GSH-Px) activities [3]. 
Work in our laboratory has demonstrated that 
cadmium cardiotoxicity is mediated by increased 
lipid peroxidation [4,5]. This peroxidative injury 
occurs only when the activity of the selenoenzyme, 
GSH-Px, is markedly reduced in cardiac cytosol 
and mitochondria [6]. These Cd-induced reduc- 
tions in GSH-Px activity were attributed to Cd-Se 
interactions in the heart since increasing dietary Se 
resulted in increased accumulations of Cd and Se 
in these hearts [6]. The existence of Cd-Se com- 
plexes has been demonstrated in erythrocytes [7]. 
Since excess GSH is added to the incubation 
mixture used to assay the activity of the selenoen- 
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zyme, GSH-Px [8], and since Cd has been shown 
to complex with GSH in vitro [9], it is entirely 
plausible that the Cd-induced reductions in 
cytosolic and mitochondrial GSH-Px activity in 
the heart [6] could be due to Cd-induced depletion 
of GSH rather than via Cd-Se interactions. Such 
Cd-GSH interactions could also contribute to the 
increased lipid peroxidation seen in the heart of 
these rats. 
To elucidate the mechanism for the Cd-induced 
reductions in GSH-Px, we determined GSH levels 
in cytosol and mitochondria from rats treated as 
described [6]. 
2. MATERIALS AND METHODS 
2.1. Biochemicals 
Reduced glutathione (GSH) and o-phthalalde- 
hyde (OPT) were obtained from Sigma. All other 
chemicals were of reagent grade and obtained from 
Fisher. 
2.2. Animal treatment 
54 male weanling Sprague-Dawley rats (Taconic 
Farms, Germantown, NY) were randomly assigned 
to the various treatment groups. The rats were fed 
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a Torula yeast-based feed low in Se (less than 
0.02 ppm by analysis, from Dyets, PA) and were 
given deionized drinking water supplemented with 
0,O. 1 or 0.5 ppm Se, as sodium selenite. The ingre- 
dients of the basal feed have been described [4,6]. 
There were two groups of Cd-treated rats. The first 
group received the basal diet supplemented with 0, 
0.1 and 0.5 ppm Se for 5 weeks. At the end of the 
5th week, these rats were given 5 mg Cd (as CdC12) 
via osmotic minipumps (Alzet 2002) implanted 
subcutaneously in the dorsal neck region under 
light pentobarbital anesthesia. The second group 
of Cd-treated rats received 50 ppm Cd (as CdC12) 
admixed with their feed for the entire 7-week ex- 
perimental period. 
2.3. Necropsy and tissue homogenization 
At the end of 7 weeks, all animals were fasted 
for 12-16 h and killed by decapitation. The heart 
was excised, weighed, blotted dry and minced us- 
ing stainless-steel scissors. A 10% (w/v) 
homogenate in 0.25 M sucrose was prepared using 
a motor-driven Teflon pestle. Mitochondrial and 
cytosolic fractions were obtained by differential 
centrifugation [lo]. 
2.4. Assay for GSH in heart cytosol and 
mitochondria 
GSH was determined in cytosolic and mitochon- 
drial fractions within 3 h of necropsy by the 
fluorometric method of Hissin and Hilf [ 111. 
Reduced GSH (Sigma) was used to construct the 
standard curve. Hence all values are reported as 
GSH equivalents, normalized for protein in the 
sample. Protein was determined according to the 
dye-binding method in [12]. 
2.5. Statistical analysis 
The data obtained were analyzed by the two-way 
analysis of variance (ANOVA) for possible signifi- 
cant interactions between the various treatment 
groups. Where interactions were found to be 
significant (P < 0.05) by the two-way ANOVA, 
significance among particular groups was deter- 
mined using the Fisher’s least significant difference 
(LSD) procedure. Since the objective of this study 
was to compare the effects of Cd at various levels 
of dietary Se, comparisons by the LSD test were 
made between either of the two Cd treatments and 
rats fed identical levels of Se without any Cd 
treatment. 
3. RESULTS 
Rats fed the basal, low-Se diet (0 ppm Se added) 
exhibited a 50% increase in cytosolic GSH com- 
pared to rats fed the diet supplemented with 0.1 or 
0.5 ppm Se without Cd (-Cd). Treatment with 
Table 1 
Effects of Cd on cytosolic and mitochondrial GSH in heart of rats fed 50 ppm Cu 
and various levels of Se for 7 weeks 
Dietary -Cd + Cd-osmotic Cd-diet 
Se (ppm) pumps 
Cytosol 
GSH 0 18.6 f 1.25 24.6 f 0.574” 22.3 f 1.6Sa 
(nmol/mg protein) 0.1 12.4 f 0.602 18.9 f 2.31b 18.7 f 1.85b 
0.5 11.2 f 1.74 13.5 + 0.977 17.3 f 2.12b 
Mitochondria 
GSH 0 11.3 + 0.816 11.1 f 0.313 11.4 f 1.93 
(nmol/mg protein) 0.1 8.72 f 1.59 11.1 f 2.93’ 12.7 f 0.671a 
0.5 7.% f 1.54 11.2 f 0.565’ 11.3 f 0.593” 
All values are reported as the x f SD of 6 rats per group. Statistical significance 
was calculated by the two-way ANOVA. Significance for Cd effects was 
determined between - Cd and either + Cd-osmotic pump or + Cd-diet groups by 
the LSD test and indicated as: * P < 0.05, b P < 0.01 
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parenteral or dietary Cd resulted in 20-50% eleva- GSH synthesis, or transport into this com- 
tions of cytosolic GSH at all levels of dietary Se. partment . 
As observed in the cytosol, Se-deficient rats ex- 
hibited a 30% higher mitochondrial GSH com- 
pared to rats fed the Se-supplemented diets in the 
absence of Cd treatment (table 1). Parenteral or 
dietary Cd did not significantly affect mitochon- 
drial GSH levels in rats fed the basal low-Se diet. 
However, rats fed the 0.1 or 0.5 ppm Se diets and 
given parenteral or dietary with Cd showed an ap- 
prox. 38% elevation in mean mitochondrial GSH 
levels. 
Whatever the precise mechanism for the effects 
of Cd on mitochondrial GSH, it is clear from our 
earlier study [6] and the present data that GSH 
depletion is not involved in Cd-induced perox- 
idative injury seen in the heart of rats fed 0 or 
0.1 ppm Se for 7 weeks. Rather, such Cd-induced 
peroxidative injury is secondary to Cd-induced 
reductions in cytoplasmic and mitochondrial GSH- 
Px activities. Studies are currently in progress to 
elucidate the mechanism of Cd effects on cardiac 
mitochondria. 
4. DISCUSSION 
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Treatment of rats with 5 mg Cd via osmotic 
pumps or feeding them 50 ppm Cd for 7 weeks 
does not deplete cytosolic or mitochondrial GSH 
in the heart. The levels of GSH reported in this 
paper are similar to values reported for the rabbit 
myocardium [3]. The elevated GSH levels in 
cytosolic fractions of the Se-deficient rat heart, or 
rats treated with Cd, exhibit a negative correlation 
(r = - 0.88936) with the reduction in the activity of 
the cytosolic GSH-Px in these animals [6]. This 
suggests that the elevation in cytosolic GSH is a 
consequence of reductions in GSH-Px activity in 
this compartment, by dietary Se deficiency and/or 
by Cd treatment. Similar observations were made 
with respect o GSH levels in cardiac mitochondria 
from Se-deficient and Se-supplemented rats, not 
treated with Cd (table 1). However, the elevated 1 
levels of mitochondrial GSH in Cd-treated rats ’ 
cannot be explained by Cd-induced reductions in 
GSH-Px activity since dietary Cd did not affect 
mitochondrial GSH-Px activity [6]. No significant 
correlation was observed between mitochondrial 
GSH-Px activity [6] and GSH levels (r = 
- 0.17643). 
Isolated hepatocytes contain two distinct pools 
of GSH, a cytoplasmic pool and a mitochondrial 
one, with the latter pool being more resistant to 
GSH depletion in vitro [13]. A similar compart- 
mentation of GSH in the heart might explain the 
differential effects of Cd in the mitochondrial frac- 
tion relative to the cytosolic one. Since dietary Cd 
does not affect mitochondrial GSH-Px activity [6] 
yet affects elevations in GSH levels in this com- 
partment (table l), Cd might affect mitochondrial 
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